AmerisourceBergen sees Q2 revenue growth

- Last updated on GMT

Related tags: Depreciation, Income statement

AmerisourceBergen’s commercial services arm was its key driver in Q2, offsetting the loss of key customer for its drug business.

Revenue for the three months ended March 31 grew 1.6 per cent to $20.1bn with the contribution from AmerisourceBergen’s specialty group (ABSG) – which provides direct to physician distribution services and commercial support – increasing by 6 per cent.

The firm said that the growth came from both its vaccine distribution business and it ‘strong’ performance by its third party logistics business.

This contrasted with AmerisourceBergen's Drug Corporation (ABDC) business – which focuses on pharmacy distribution, staffing and market consulting services – which the firm said had generated flat revenue compared with the year-earlier quarter largely due to the loss of an unidentified retail customer.

Despite the revenue growth operating income for the period increased only modestly, climbing just 0.8 percent to $368 m due – according to the firm - to higher costs.

The increase in operating expenses was driven by $9.0m in employee severance and acquisition-related transaction costs, the operating expenses of our recently acquired companies, and increased depreciation and amortization expenses, which was offset in large part by a significant improvement in distribution, selling and administrative expenses​.”

CEO Steven Collis was upbeat about the performance, commenting that:  "We overcame a challenging comparison with the prior year, we continued to demonstrate tremendous expense and working capital discipline, and our balance sheet remains strong, giving us outstanding financial flexibility​.”

He also spoke about AmerisourceBergen’s acquisitions – explaining that the integration of reimbursement services firm Theracom​ is on track and that the planned purchase of trial distribution services provider World Courier​ is about to complete. 

We expect to complete our $520m acquisition of World Courier Group by the end of April, and we are excited to welcome their 2,500 associates to AmerisourceBergen, and to explore the possibilities of extending our capabilities in select international markets​."

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Related suppliers

Follow us


View more